Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
4.570
+0.215 (4.94%)
At close: Aug 13, 2025, 4:00 PM
4.610
+0.040 (0.88%)
After-hours: Aug 13, 2025, 5:52 PM EDT
Vir Biotechnology Employees
Vir Biotechnology had 408 employees as of December 31, 2024. The number of employees decreased by 179 or -30.49% compared to the previous year.
Employees
408
Change (1Y)
-179
Growth (1Y)
-30.49%
Revenue / Employee
$46,569
Profits / Employee
-$1,348,600
Market Cap
634.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VIR News
- 6 days ago - Vir Biotechnology, Inc. (VIR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results - Business Wire
- 7 days ago - Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta - Business Wire
- 13 days ago - Vir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta - Business Wire
- 20 days ago - Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors - Business Wire
- 21 days ago - Vir Biotechnology: Hep B And Cancer Projects March On - Seeking Alpha
- 22 days ago - Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
- 2 months ago - 20 stocks you should avoid — no matter how well the market does - Market Watch